Eur Rev Med Pharmacol Sci 2016; 20 (24): 5186-5192

MiR-365 participates in coronary atherosclerosis through regulating IL-6

B. Lin, D.-G. Feng, F. Wang, J.-X. Wang, C.-G. Xu, H. Zhao, Z.-Y. Cheng

Department of Cardiovascular Surgery, Henan Provincial People’s Hospital, Zheng Zhou, China. cfn777@126.com


OBJECTIVE: This study aims to investigate the role and mechanism of miR-365 in the coronary atherosclerosis (AS).

PATIENTS AND METHODS: Blood were collected from AS patients and healthy people, coronary plaque and adjacent arterial tissue were collected from AS patients. QRT-PCR method was used to detect expressions of miR-365 and IL-6 in coronary plaque, blood monocytes, and serum. Western blot was applied to detect IL-6 protein expression in coronary plaque and blood monocytes, and ELISA was used to detect IL-6 protein expression in serum.

RESULTS: Compared with the normal group, IL-6 expression was significantly increased in coronary plaque, blood monocytes, and serum both in mRNA level and in protein level, while miR-365 expression was significantly decreased (p < 0.05).

CONCLUSIONS: IL-6 expression was significantly up-regulated in coronary plaque, blood monocytes, and serum, whereas miR-365 expression was down-regulated. MiR-365 may regulate the pathogenesis and immune response in AS through targeting IL-6.

Free PDF Download

To cite this article

B. Lin, D.-G. Feng, F. Wang, J.-X. Wang, C.-G. Xu, H. Zhao, Z.-Y. Cheng
MiR-365 participates in coronary atherosclerosis through regulating IL-6

Eur Rev Med Pharmacol Sci
Year: 2016
Vol. 20 - N. 24
Pages: 5186-5192